TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
---|---|---|---|---|---|---|---|---|---|---|---|
P | %ret | 1 | 1 | 4 | 2 | 13 | 9 | 20 | 40 | 18 | 17 |
P | %wins | 75 | 100 | 50 | 100 | 100 | 100 | 88 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2/15/17 16:17 | 2/13/17 | VRML | Vermillion, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Lafrance James T | TX | D | P.d | 9 | 1.40 | 0 | 7 | 4 | 190 | D | -23 | 30 | 22 | 29 | 45 | 24 | 26 | 16 | -6 | 22 | 27 | ||||
12/23/14 16:17 | 12/19/14 | VRML | Vermillion, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Lafrance James T | TX | DO | P,Chief | P.d | 24 | 1.44 | 0 | 17 | 21 | 95 | D | 6 | -40 | -45 | -21 | 2 | 3 | 14 | 8 | 9 | 18 | 13 | 13 | 34 | 10 |
11/21/14 17:45 | 11/20/14 | VRML | Vermillion, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Lafrance James T | TX | DO | P,Chief | P | 40 | 1.44 | 0 | 28 | 56 | 78 | D | 27 | -36 | -42 | -32 | -8 | -6 | 2 | 14 | 3 | 3 | -3 | 22 | 45 | 21 |
11/20/14 17:10 | 11/18/14 | VRML | Vermillion, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Lafrance James T | TX | DO | P,Chief | P.m | 59 | 1.43 | 0 | 42 | 490 | 50 | D | 19 | -35 | -49 | -32 | -10 | -6 | 3 | 3 | 2 | 7 | -1 | 26 | 41 | 23 |
D | Derivative transaction in filing (usually option exercise) |
M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
A | Amended filing |
E | Error detected in filing |
S - Sale | Sale of securities on an exchange or to another person |
S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
P - Purchase | Purchase of securities on an exchange or from another person |